{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:16:59Z","timestamp":1789564619687,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1135837"],"award-info":[{"award-number":["GNT1135837"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1182996"],"award-info":[{"award-number":["GNT1182996"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2001027"],"award-info":[{"award-number":["GNT2001027"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2001178"],"award-info":[{"award-number":["GNT2001178"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bcp.2024.116239","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T02:12:00Z","timestamp":1714183920000},"page":"116239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4"],"prefix":"10.1016","volume":"224","author":[{"given":"Hongkang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.G.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley L.","family":"Hoare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herodion A.","family":"Hartono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.D.","family":"Bathgate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Akhter","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bcp.2024.116239_b0005","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2036.2010.04273.x","article-title":"Systematic review: impact of constipation on quality of life in adults and children","volume":"31","author":"Belsey","year":"2010","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116239_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e6168","article-title":"Laxatives for chronic constipation in adults","volume":"345","author":"Ford","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.bcp.2024.116239_b0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1592\/phco.25.4.620.61032","article-title":"Tegaserod-associated ischemic colitis","volume":"25","author":"DiBaise","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.bcp.2024.116239_b0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","article-title":"Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives","volume":"58","author":"Tack","year":"2009","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bcp.2024.116239_b0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/nmo.12553","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride","volume":"27","author":"Piessevaux","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"issue":"22","key":"10.1016\/j.bcp.2024.116239_b0030","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1056\/NEJMoa0800670","article-title":"A placebo-controlled trial of prucalopride for severe chronic constipation","volume":"358","author":"Camilleri","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2024.116239_b0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1572-0241.2006.00459.x","article-title":"Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data","volume":"101","author":"Chang","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bcp.2024.116239_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/928507","article-title":"The impact of simulated and real microgravity on bone cells and mesenchymal stem cells","volume":"2014","author":"Ulbrich","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.bcp.2024.116239_b0045","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1073\/pnas.1411413111","article-title":"Insulin-like peptide 5 is an orexigenic gastrointestinal hormone","volume":"111","author":"Grosse","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.bcp.2024.116239_b0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1074\/jbc.M409916200","article-title":"INSL5 is a high affinity specific agonist for GPCR142 (GPR100)","volume":"280","author":"Liu","year":"2005","journal-title":"J. f Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116239_b0055","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2013.02.042","article-title":"INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors","volume":"432","author":"Mashima","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116239_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-022-03635-8","article-title":"Expression of the relaxin family peptide 4 receptor by enterochromaffin cells of the mouse large intestine","volume":"389","author":"Koo","year":"2022","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2024.116239_b0065","doi-asserted-by":"crossref","unstructured":"J. Grosse, H. Heffron, K. Burling, M.A. Hossain, A.M. Habib, G.J. Rogers, P. Richards, R. Larder, D. Rimmington, A.A. Adriaenssens, Insulin-like peptide 5 is an orexigenic gastrointestinal hormone, Proc. Natl. Acad. Sci. 111(30) (2014) 11133-11138.","DOI":"10.1073\/pnas.1411413111"},{"issue":"3","key":"10.1016\/j.bcp.2024.116239_b0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/BJ20141113","article-title":"The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo","volume":"466","author":"Luo","year":"2015","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.bcp.2024.116239_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-021-02335-x","article-title":"Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer","volume":"19","author":"Yang","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116239_b0080","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/cbic.200800113","article-title":"Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5)","volume":"9","author":"Hossain","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.bcp.2024.116239_b0085","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00726-010-0586-3","article-title":"Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5","volume":"39","author":"Luo","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.bcp.2024.116239_b0090","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1021\/acs.jmedchem.5b01786","article-title":"Engineering of a novel simplified human insulin-like peptide 5 Agonist","volume":"59","author":"Patil","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2024.116239_b0095","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13796","article-title":"Colokinetic effect of an insulin-like peptide 5-related agonist of the RXFP4 receptor","volume":"32","author":"Diwakarla","year":"2020","journal-title":"Neurogastroenterol. Motil."},{"issue":"12","key":"10.1016\/j.bcp.2024.116239_b0100","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/acsmedchemlett.0c00435","article-title":"Human Insulin-like Peptide 5 (INSL5). Identification of a Simplified Version of Two-Chain Analog A13,","volume":"11","author":"Zhang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2024.116239_b0105","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/acsptsci.1c00171","article-title":"A novel antagonist peptide reveals a physiological role of insulin-like peptide 5 in control of colorectal function","volume":"4","author":"Pustovit","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116239_b0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41467-023-36182-z","article-title":"Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4)","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2024.116239_b0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1071\/CH19427","article-title":"The 9-fluorenylmethoxycarbonyl (Fmoc) group in chemical peptide synthesis\u2013its past, present, and future","volume":"73","author":"Li","year":"2019","journal-title":"Austr. J. Chem."},{"key":"10.1016\/j.bcp.2024.116239_b0120","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00726-012-1305-z","article-title":"Chemical synthesis and biological evaluation of an antimicrobial peptide gonococcal growth inhibitor","volume":"43","author":"Wade","year":"2012","journal-title":"Amino Acids"},{"issue":"16","key":"10.1016\/j.bcp.2024.116239_b0125","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1021\/acs.jmedchem.6b00265","article-title":"Development of a single-chain peptide agonist of the relaxin-3 receptor using hydrocarbon stapling","volume":"59","author":"Hojo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116239_b0130","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1021\/ja973966s","article-title":"Enhancing the proline effect: pseudo-prolines for tailoring cis\/trans isomerization","volume":"120","author":"Keller","year":"1998","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.bcp.2024.116239_b0135","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/cbic.200800113","article-title":"Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5)","volume":"9","author":"Akhter Hossain","year":"2008","journal-title":"Chembiochem"},{"key":"10.1016\/j.bcp.2024.116239_b0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10989-008-9148-x","article-title":"Simultaneous post-cysteine (S-Acm) group removal quenching of iodine and isolation of peptide by one step ether precipitation","volume":"14","author":"Zhang","year":"2008","journal-title":"Int. J. Peptide Res. Therap."},{"key":"10.1016\/j.bcp.2024.116239_b0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10989-006-9020-9","article-title":"Regioselective disulfide solid phase synthesis, chemical characterization and in vitro receptor binding activity of equine relaxin","volume":"12","author":"Hossain","year":"2006","journal-title":"Int. J. Peptide Res. Therap."},{"issue":"18","key":"10.1016\/j.bcp.2024.116239_b0150","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1021\/bi700238h","article-title":"Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin","volume":"46","author":"Samuel","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2024.116239_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116238","article-title":"Development of a synthetic relaxin-3\/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays","volume":"224","author":"Wu","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"39","key":"10.1016\/j.bcp.2024.116239_b0160","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1021\/bi201093m","article-title":"Structure and function relationship of murine insulin-like peptide 5 (INSL5): free C-terminus is essential for RXFP4 receptor binding and activation","volume":"50","author":"Belgi","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2024.116239_b0165","unstructured":"S. Maestro, Maestro, Schr\u00f6dinger, LLC, New York, NY 2020 (2020) 682."},{"issue":"7873","key":"10.1016\/j.bcp.2024.116239_b0170","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116239_b0175","doi-asserted-by":"crossref","unstructured":"K.J. Bowers, E. Chow, H. Xu, R.O. Dror, M.P. Eastwood, B.A. Gregersen, J.L. Klepeis, I. Kolossvary, M.A. Moraes, F.D. Sacerdoti, Scalable algorithms for molecular dynamics simulations on commodity clusters, Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, 2006, pp. 84-es.","DOI":"10.1145\/1188455.1188544"},{"issue":"7","key":"10.1016\/j.bcp.2024.116239_b0180","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: Improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.bcp.2024.116239_b0185","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1021\/acs.jmedchem.5b01786","article-title":"Engineering of a novel simplified human insulin-like peptide 5 agonist","volume":"59","author":"Patil","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116239_b0190","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00726-015-2144-5","article-title":"The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity","volume":"48","author":"Patil","year":"2016","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.bcp.2024.116239_b0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pharmthera.2014.02.004","article-title":"Unifying family A GPCR theories of activation","volume":"143","author":"Tehan","year":"2014","journal-title":"Pharmacol. Therap."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224002223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:09:27Z","timestamp":1777381767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224002223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":39,"alternative-id":["S0006295224002223"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116239","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116239"}}